Dyadic International Q2 EPS misses by $0.03, revenue misses by $0.67M

Seeking Alpha··Read original
2▲0 ▼1Impact / 5
Summary · why it matters

Dyadic International reported second quarter 2026 financial results with a GAAP loss per share of $0.06, missing expectations by $0.03, and revenue of $0.96 million, down 1.0% year over year and missing estimates by $0.67 million. Research and development expenses fell 47.2% to $332,621 due to fewer active internal research initiatives, while general and administrative expenses rose 17.6% to $1,689,863 on higher rebranding, business development, legal, and accounting costs. Loss from operations widened 18.8% to $2,054,204, driven by higher cost of revenue and G&A expenses, partially offset by lower R&D spending.

Impact on assets 1

Synthetic Biology (non-pharma)▼ · 1 stocks